Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Tumor necrosis factor α is associated with viral control and early disease progression in patients with HIV type 1 infection.

Vaidya SA, Korner C, Sirignano MN, Amero M, Bazner S, Rychert J, Allen TM, Rosenberg ES, Bosch RJ, Altfeld M.

J Infect Dis. 2014 Oct 1;210(7):1042-6. doi: 10.1093/infdis/jiu206. Epub 2014 Mar 31.

2.

Acute plasma biomarkers of T cell activation set-point levels and of disease progression in HIV-1 infection.

Liovat AS, Rey-Cuillé MA, Lécuroux C, Jacquelin B, Girault I, Petitjean G, Zitoun Y, Venet A, Barré-Sinoussi F, Lebon P, Meyer L, Sinet M, Müller-Trutwin M.

PLoS One. 2012;7(10):e46143. doi: 10.1371/journal.pone.0046143. Epub 2012 Oct 2.

3.

[Innate immunity restoration in patients with HIV/AIDS infection associated with antiretroviral therapy].

Afani A, Jiusán L, Raby P, Sitia G, Puente J, Sepúlveda C, Miranda D, Cabrera R, Guidotti L, Lanza P.

Rev Med Chil. 2006 Jun;134(6):689-96. Epub 2006 Aug 14. Spanish.

4.

Structured intermittent interruption of chronic HIV infection treatment with highly active antiretroviral therapy: effects on leptin and TNF-alpha.

Arjona MM, Pérez-Cano R, Garcia-Juárez R, Martín-Aspas A, del Alamo CF, Girón-González JA.

AIDS Res Hum Retroviruses. 2006 Apr;22(4):307-14.

6.

Genital tract inflammation during early HIV-1 infection predicts higher plasma viral load set point in women.

Roberts L, Passmore JA, Mlisana K, Williamson C, Little F, Bebell LM, Walzl G, Abrahams MR, Woodman Z, Abdool Karim Q, Abdool Karim SS.

J Infect Dis. 2012 Jan 15;205(2):194-203. doi: 10.1093/infdis/jir715.

7.

Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.

Sterling TR, Vlahov D, Astemborski J, Hoover DR, Margolick JB, Quinn TC.

N Engl J Med. 2001 Mar 8;344(10):720-5.

8.

Viral load and disease progression as responsible for endothelial activation and/or injury in human immunodeficiency virus-1-infected patients.

de Larrañaga GF, Petroni A, Deluchi G, Alonso BS, Benetucci JA.

Blood Coagul Fibrinolysis. 2003 Jan;14(1):15-8.

PMID:
12544723
9.

The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of women.

Keating SM, Golub ET, Nowicki M, Young M, Anastos K, Crystal H, Cohen MH, Zhang J, Greenblatt RM, Desai S, Wu S, Landay AL, Gange SJ, Norris PJ; Women's Interagency HIV Study.

AIDS. 2011 Sep 24;25(15):1823-32. doi: 10.1097/QAD.0b013e3283489d1f.

10.

Deficiency of HIV-Gag-specific T cells in early childhood correlates with poor viral containment.

Huang S, Dunkley-Thompson J, Tang Y, Macklin EA, Steel-Duncan J, Singh-Minott I, Ryland EG, Smikle M, Walker BD, Christie CD, Feeney ME.

J Immunol. 2008 Dec 1;181(11):8103-11.

11.

Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements.

Fahey JL, Taylor JM, Manna B, Nishanian P, Aziz N, Giorgi JV, Detels R.

AIDS. 1998 Sep 10;12(13):1581-90.

PMID:
9764776
12.

Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy.

Hogg RS, Yip B, Chan KJ, Wood E, Craib KJ, O'Shaughnessy MV, Montaner JS.

JAMA. 2001 Nov 28;286(20):2568-77.

PMID:
11722271
13.

Rapid disease progression in human immunodeficiency virus type 1-infected seroconverters in India.

Mehendale SM, Bollinger RC, Kulkarni SS, Stallings RY, Brookmeyer RS, Kulkarni SV, Divekar AD, Gangakhedkar RR, Joshi SN, Risbud AR, Thakar MA, Mahajan BA, Kale VA, Ghate MV, Gadkari DA, Quinn TC, Paranjape RS.

AIDS Res Hum Retroviruses. 2002 Nov 1;18(16):1175-9.

PMID:
12487823
14.

Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markers.

Ostrowski SR, Katzenstein TL, Pedersen BK, Gerstoft J, Ullum H.

Scand J Immunol. 2008 Dec;68(6):652-60. doi: 10.1111/j.1365-3083.2008.02184.x.

15.

Early evolution of plasma soluble TNF-alpha p75 receptor as a marker of progression in treated HIV-infected patients.

Morlat P, Pereira E, Clayette P, Derreudre-Bosquet N, Ecobichon JL, Benveniste O, Saves M, Leport C; ANRS CO8 Aproco-Copilote Study Group.

AIDS Res Hum Retroviruses. 2008 Nov;24(11):1383-9. doi: 10.1089/aid.2007.0293.

PMID:
18928394
16.

Plasma levels of soluble CD30, tumour necrosis factor (TNF)-alpha and TNF receptors during primary HIV-1 infection: correlation with HIV-1 RNA and the clinical outcome.

Rizzardi GP, Barcellini W, Tambussi G, Lillo F, Malnati M, Perrin L, Lazzarin A.

AIDS. 1996 Nov;10(13):F45-50.

PMID:
8931778
17.

Immunization with both T cell-dependent and T cell-independent vaccines augments HIV viral load secondarily to stimulation of tumor necrosis factor alpha.

Viganò A, Bricalli D, Trabattoni D, Salvaggio A, Ruzzante S, Barbi M, Di Sanzo G, Principi N, Clerici M.

AIDS Res Hum Retroviruses. 1998 Jun 10;14(9):727-34.

PMID:
9643372
18.

Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection.

Musey L, Hughes J, Schacker T, Shea T, Corey L, McElrath MJ.

N Engl J Med. 1997 Oct 30;337(18):1267-74.

19.
20.

Impact of select immunologic and virologic biomarkers on CD4 cell count decrease in patients with chronic HIV-1 subtype C infection: results from Sinikithemba Cohort, Durban, South Africa.

Brumme Z, Wang B, Nair K, Brumme C, de Pierres C, Reddy S, Julg B, Moodley E, Thobakgale C, Lu Z, van der Stok M, Bishop K, Mncube Z, Chonco F, Yuki Y, Frahm N, Brander C, Carrington M, Freedberg K, Kiepiela P, Goulder P, Walker B, Ndung'u T, Losina E.

Clin Infect Dis. 2009 Sep 15;49(6):956-64. doi: 10.1086/605503.

Supplemental Content

Support Center